Two Sigma Advisers’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-104,749
| Closed | -$28K | – | 2775 |
|
|
2022
Q3 | $28K | Buy |
104,749
+60,700
| +138% | +$26.5K | ﹤0.01% | 2424 |
|
|
2022
Q2 | $34K | Sell |
44,049
-73,680
| -63% | -$65.7K | ﹤0.01% | 2511 |
|
|
2022
Q1 | $126K | Sell |
117,729
-172,500
| -59% | -$313K | ﹤0.01% | 2472 |
|
|
2021
Q4 | $551K | Sell |
290,229
-36,900
| -11% | -$88.4K | ﹤0.01% | 1871 |
|
|
2021
Q3 | $985K | Buy |
327,129
+197,500
| +152% | +$703K | ﹤0.01% | 1629 |
|
|
2021
Q2 | $507K | Sell |
129,629
-47,900
| -27% | -$199K | ﹤0.01% | 1931 |
|
|
2021
Q1 | $900K | Buy |
177,529
+25,700
| +17% | +$133K | ﹤0.01% | 1713 |
|
|
2020
Q4 | $621K | Buy |
151,829
+89,600
| +144% | +$440K | ﹤0.01% | 1786 |
|
|
2020
Q3 | $302K | Hold |
62,229
| – | – | ﹤0.01% | 2009 |
|
|
2020
Q2 | $345K | Buy |
62,229
+6,700
| +12% | +$30.7K | ﹤0.01% | 2058 |
|
|
2020
Q1 | $182K | Buy |
55,529
+4,400
| +9% | +$23.2K | ﹤0.01% | 2194 |
|
|
2019
Q4 | $231K | Hold |
51,129
| – | – | ﹤0.01% | 2143 |
|
|
2019
Q3 | $213K | Sell |
51,129
-300
| -0.6% | -$1.08K | ﹤0.01% | 2025 |
|
|
2019
Q2 | $195K | Sell |
51,429
-17,900
| -26% | -$73.4K | ﹤0.01% | 2136 |
|
|
2019
Q1 | $290K | Sell |
69,329
-11,400
| -14% | -$39.8K | ﹤0.01% | 2000 |
|
|
2018
Q4 | $201K | Buy |
80,729
+48,922
| +154% | +$287K | ﹤0.01% | 2133 |
|
|
2018
Q3 | $232K | Buy |
31,807
+14,100
| +80% | +$61.7K | ﹤0.01% | 2041 |
|
|
2018
Q2 | $66K | Buy |
17,707
+500
| +3% | +$2.31K | ﹤0.01% | 2293 |
|
|
2018
Q1 | $66K | Sell |
17,207
-4,000
| -19% | -$16.8K | ﹤0.01% | 2247 |
|
|
2017
Q4 | $76K | Buy |
+21,207
| New | +$80.1K | ﹤0.01% | 2171 |
|
|
2016
Q1 | – | Sell |
-11,888
| Closed | -$243K | – | 2172 |
|
|
2015
Q4 | $243K | Buy |
+11,888
| New | +$183K | ﹤0.01% | 1592 |
|
Two Sigma Advisers's AGTC Position: Q4 2022 in Review
Two Sigma Advisers sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 104,749 shares — an estimated $28K sold.
Two Sigma Advisers first reported a position in AGTC in Q4 2015 and held it in 21 quarters. The position peaked at $985K in Q3 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Two Sigma Advisers reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Two Sigma Advisers sold 104,749 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $28K.
- Two Sigma Advisers first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 21 quarters.
- Two Sigma Advisers's Applied Genetic Technologies Corporation position peaked at $985K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.